CV Sciences, Inc. Announces PlusCBD™ Brand Refresh and New Product Launches
October 06, 2020 07:00 ET
|
CV Sciences, Inc.
SAN DIEGO, Oct. 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...
Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call
August 20, 2020 10:51 ET
|
Exactus, Inc.
Second Quarter 2020 Highlights Total Net Revenue of $531,240Continuation of Sales & Marketing BuildoutWhite Label Division LaunchEuropean Sales ExpansionStrengthened the Balance Sheet DELRAY...
CV Sciences, Inc. Reports Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
VERUS INTERNATIONAL SETS INITIAL CBD PRODUCT SHIPMENT SCHEDULE
August 04, 2020 12:54 ET
|
Verus International, Inc.
Gaithersburg, MD, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTCQB: VRUS) is providing the following corporate update in order to give analysts and...
CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
Greater Cannabis Launches CBD Oral Patch Product With European Partner Symtomax
June 12, 2020 08:00 ET
|
The Greater Cannabis Company, Inc.
BALTIMORE, MD, June 12, 2020 (GLOBE NEWSWIRE) -- Greater Cannabis Company (OTCQB: GCAN), an innovator in the development and commercialization of cannabinoid delivery systems and cannabinoids...
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020
May 20, 2020 16:30 ET
|
CV Sciences, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today...
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
May 20, 2020 08:00 ET
|
CV Sciences, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Reports First Quarter 2020 Financial Results
May 08, 2020 07:00 ET
|
CV Sciences, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce First Quarter 2019 Results on May 8, 2020
April 30, 2020 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, April 30, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...